Next-generation gene-editing tools to boost the efficiency and safety of advanced therapies.
Integra Therapeutics has raised €27M across 4 funding rounds from 9 investors, most recently a Seed round in Sep 2025. Based in Barcelona, Spain; active in Healthtech. Data as of 6 Aug 2026.
Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-09-09 | Seed | €11M | AdBio partners,CDTI Innvierte,Columbus Venture Partners,EIC Fund,Invivo Partners,Takeda Ventures | View deal → |
| 2024-07-17 | Other | €11M | European Innovation Council (EIC) Accelerator Programme | View deal → |
| 2022-03-29 | Other | €1.5M | Columbus Venture Partners | View deal → |
| 2021-12-02 | Other | €4.5M | Advent France Biotechnology,Invivo Capita I,Takeda Ventures | View deal → |
